Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.220
-0.055 (-2.42%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.020 (0.90%)
After-hours: Dec 5, 2025, 7:30 PM EST

Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $377.26 million. The enterprise value is $225.82 million.

Market Cap 377.26M
Enterprise Value 225.82M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

NMRA has 169.94 million shares outstanding. The number of shares has increased by 2.49% in one year.

Current Share Class 167.09M
Shares Outstanding 169.94M
Shares Change (YoY) +2.49%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 4.82%
Owned by Institutions (%) 30.43%
Float 89.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.72
P/TBV Ratio 2.85
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.15.

Current Ratio 6.85
Quick Ratio 6.64
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -203.38

Financial Efficiency

Return on equity (ROE) is -104.35% and return on invested capital (ROIC) is -63.22%.

Return on Equity (ROE) -104.35%
Return on Assets (ROA) -56.71%
Return on Invested Capital (ROIC) -63.22%
Return on Capital Employed (ROCE) -158.30%
Revenue Per Employee n/a
Profits Per Employee -$2.15M
Employee Count 110
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NMRA has paid $130,000 in taxes.

Income Tax 130,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.28% in the last 52 weeks. The beta is 3.16, so NMRA's price volatility has been higher than the market average.

Beta (5Y) 3.16
52-Week Price Change -77.28%
50-Day Moving Average 2.27
200-Day Moving Average 1.47
Relative Strength Index (RSI) 44.32
Average Volume (20 Days) 1,140,160

Short Selling Information

The latest short interest is 6.10 million, so 3.59% of the outstanding shares have been sold short.

Short Interest 6.10M
Short Previous Month 6.54M
Short % of Shares Out 3.59%
Short % of Float 6.81%
Short Ratio (days to cover) 2.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -240.60M
Pretax Income -236.17M
Net Income -236.30M
EBITDA -240.24M
EBIT -240.60M
Earnings Per Share (EPS) -$1.46
Full Income Statement

Balance Sheet

The company has $171.53 million in cash and $20.09 million in debt, giving a net cash position of $151.44 million or $0.89 per share.

Cash & Cash Equivalents 171.53M
Total Debt 20.09M
Net Cash 151.44M
Net Cash Per Share $0.89
Equity (Book Value) 132.16M
Book Value Per Share 0.82
Working Capital 151.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$208.83 million and capital expenditures $759,000, giving a free cash flow of -$208.07 million.

Operating Cash Flow -208.83M
Capital Expenditures 759,000
Free Cash Flow -208.07M
FCF Per Share -$1.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.49%
Shareholder Yield -2.49%
Earnings Yield -62.63%
FCF Yield -55.15%

Analyst Forecast

The average price target for NMRA is $8.00, which is 260.36% higher than the current price. The consensus rating is "Buy".

Price Target $8.00
Price Target Difference 260.36%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1